Efficacy and safety of medical cannabinoids in older subjects: A systematic review

@article{Elsen2014EfficacyAS,
  title={Efficacy and safety of medical cannabinoids in older subjects: A systematic review},
  author={G. A. V. D. Elsen and A. A. I. Ahmed and M. Lammers and C. Kramers and M. G. Rikkert},
  journal={Ageing Research Reviews},
  year={2014},
  volume={14},
  pages={56-64}
}
  • G. A. V. D. Elsen, A. A. I. Ahmed, +2 authors M. G. Rikkert
  • Published 2014
  • Medicine
  • Ageing Research Reviews
  • This systematic review aims to integrate the evidence on indications, efficacy, safety and pharmacokinetics of medical cannabinoids in older subjects. The literature search was conducted using PubMed, EMBASE, CINAHL and Cochrane Library. We selected controlled trials including solely older subjects (≥65 years) or reporting data on older subgroups. 105 (74%) papers, on controlled intervention trials, reported the inclusion of older subjects. Five studies reported data on older persons separately… CONTINUE READING
    Medical Cannabis for Older Patients
    • 16
    Cannabinoids in the Older Person: A Literature Review

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 43 REFERENCES
    Cannabinoids for epilepsy.
    • 179
    • PDF
    Cannabis for dyskinesia in Parkinson disease
    • 127
    Cannabidiol for the treatment of psychosis in Parkinson’s disease
    • 188